BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perteghella S, Sottani C, Coccè V, Negri S, Cavicchini L, Alessandri G, Cottica D, Torre ML, Grignani E, Pessina A. Paclitaxel-Loaded Silk Fibroin Nanoparticles: Method Validation by UHPLC-MS/MS to Assess an Exogenous Approach to Load Cytotoxic Drugs. Pharmaceutics 2019;11:E285. [PMID: 31213025 DOI: 10.3390/pharmaceutics11060285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Florczak A, Grzechowiak I, Deptuch T, Kucharczyk K, Kaminska A, Dams-Kozlowska H. Silk Particles as Carriers of Therapeutic Molecules for Cancer Treatment. Materials (Basel) 2020;13:E4946. [PMID: 33158060 DOI: 10.3390/ma13214946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bari E, Serra M, Paolillo M, Bernardi E, Tengattini S, Piccinini F, Lanni C, Sorlini M, Bisbano G, Calleri E, Torre ML, Perteghella S. Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp Cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery. Cancers (Basel) 2021;13:1185. [PMID: 33803385 DOI: 10.3390/cancers13051185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Carissimi G, Montalbán MG, Víllora G, Barth A. Direct Quantification of Drug Loading Content in Polymeric Nanoparticles by Infrared Spectroscopy. Pharmaceutics 2020;12:E912. [PMID: 32977658 DOI: 10.3390/pharmaceutics12100912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mobika J, Rajkumar M, Nithya Priya V, Linto Sibi S. Substantial effect of silk fibroin reinforcement on properties of hydroxyapatite/silk fibroin nanocomposite for bone tissue engineering application. Journal of Molecular Structure 2020;1206:127739. [DOI: 10.1016/j.molstruc.2020.127739] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
5 Golinelli G, Mastrolia I, Aramini B, Masciale V, Pinelli M, Pacchioni L, Casari G, Dall'Ora M, Soares MBP, Damasceno PKF, Silva DN, Dominici M, Grisendi G. Arming Mesenchymal Stromal/Stem Cells Against Cancer: Has the Time Come? Front Pharmacol 2020;11:529921. [PMID: 33117154 DOI: 10.3389/fphar.2020.529921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Jafari A, Babajani A, Abdollahpour-Alitappeh M, Ahmadi N, Rezaei-Tavirani M. Exosomes and cancer: from molecular mechanisms to clinical applications. Med Oncol 2021;38:45. [PMID: 33743101 DOI: 10.1007/s12032-021-01491-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
7 Al Saqr A, Wani SUD, Gangadharappa HV, Aldawsari MF, Khafagy ES, Lila ASA. Enhanced Cytotoxic Activity of Docetaxel-Loaded Silk Fibroin Nanoparticles against Breast Cancer Cells. Polymers (Basel) 2021;13:1416. [PMID: 33925581 DOI: 10.3390/polym13091416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]